Tammee M. Parsons
Jacksonville College(US)Mayo Clinic in Florida(US)
Publications by Year
Research Areas
Amyotrophic Lateral Sclerosis Research, Alzheimer's disease research and treatments, Mesenchymal stem cell research, Neuroinflammation and Neurodegeneration Mechanisms, Parkinson's Disease Mechanisms and Treatments
Most-Cited Works
- → Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study(2018)124 cited
- → Loss of TMEM106B leads to myelination deficits: implications for frontotemporal dementia treatment strategies(2020)79 cited
- → Loss of Tmem106b exacerbates FTLD pathologies and causes motor deficits in progranulin‐deficient mice(2020)67 cited
- → ABCA7 deficiency causes neuronal dysregulation by altering mitochondrial lipid metabolism(2023)45 cited
- → Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicity(2018)23 cited
- → LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4(2023)20 cited
- → Secretome from iPSC-derived MSCs exerts proangiogenic and immunosuppressive effects to alleviate radiation-induced vascular endothelial cell damage(2024)19 cited
- → A mutant methionyl-tRNA synthetase-based toolkit to assess induced-mesenchymal stromal cell secretome in mixed-culture disease models(2023)9 cited
- → Human iPSC-Derived MSCs Induce Neurotrophic Effects and Improve Metabolic Activity in Acute Neuronal Injury Models(2024)8 cited
- → Brain-targeting liposome-based APOE2 gene delivery exacerbates soluble amyloid-β accumulation in AppNL−G-F mice(2024)5 cited